Hospitals Press Device Makers on Pricing as Surgical Volumes Hold Steady
Hospital systems entering the final quarter of the year are leaning harder on group purchasing contracts, asking device makers to justify prices line by line even as elective surgical volumes hold roughly steady, according to several supply-chain executives.
The pressure is landing unevenly. Larger suppliers can bundle products across many surgical specialties; smaller manufacturers selling into one procedure category have fewer ways to offset price concessions, and tend to be watched more closely by investors for cash and loan covenants.
Reading a medtech company's filings: what to check first
sample-newsnetwork.example
"Growth is still the headline, but the first question now is how long the cash lasts," said one healthcare analyst.
Analysts say the filings matter more than the pitch. Quarterly reports, loan terms and going-concern language are being read as closely as revenue lines, particularly at companies that raised debt last year.